During an April 23rd FDA hearing to gather input on ways to modernize the clinical research process, The Association of Clinical Research Organizations (ACRO) provided FDA a number of suggestions to improve the drug development process. ACRO’s main suggestion was to...
According to a report by the Institute of Medicine (IOM), the National Cancer Institute’s (NCI) Clinical Trials Cooperative Group program was inefficient, underfunded, and filled with red tape. The NCI program contains 3,100 institutions in the U.S., Canada, and...
According to an editorial published in the January edition of the British Medical Journal, researchers often do not report relevant clinical trial data. The editorialists said the problem is missing data, “We are not dealing here with trial design, hidden bias or...
The Association of Clinical Research Organizations (ACRO) has launched a new YouTube channel to educate the public, media, and policymakers about clinical trials. ACRO believes it has an obligation to keep people informed about clinical trials, “…we have an...
A new study released by the international journal Sociology of Health and Illness shows that cancer trials are too long, filled with jargon, and can be intimidating. The study consisted of 13 cancer trials and 26 patients. The authors of the study found that the...
In the last 5 years, big pharma has continued its move toward large molecules and biologics for drug development. Two recent studies from Withers & Rogers (a UK law firm specializing in IP) and KMR Group (a pharma consultancy) report on some of the trends among...
